Tags : Research and Licensing Agreement

Janssen Extends its Research and Licensing Agreement with SVI to

Shots: SVI to receive development milestones, royalties and option exercise fee. Janssen to exercise its option and will be responsible for all development of small molecule modulators of microglial function and inflammation for Alzheimer’s disease In Aug’2017, Janssen collaborated with SVI to develop & commercialize small molecule modulators of microglial function and inflammation focusing the […]Read More